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Abstract
Minimally invasive approaches to detect/predict target organ toxicity have significant practical 
applications in occupational toxicology. The potential application of peripheral blood 
transcriptomics as a practical approach to study the mechanisms of silica-induced pulmonary 
toxicity was investigated. Rats were exposed by inhalation to crystalline silica (15 mg/m3, 6 h/day, 
5 days) and pulmonary toxicity and global gene expression profiles of lungs and peripheral blood 
were determined at 32 weeks following termination of exposure. A significant elevation in 
bronchoalveolar lavage fluid lactate dehydrogenase activity and moderate histological changes in 
the lungs, including type II pneumocyte hyperplasia and fibrosis, indicated pulmonary toxicity in 
the rats. Similarly, significant infiltration of neutrophils and elevated monocyte chemotactic 
protein-1 levels in the lungs showed pulmonary inflammation in the rats. Microarray analysis of 
global gene expression profiles identified significant differential expression [>1.5-fold change and 
false discovery rate (FDR) p < 0.01] of 520 and 537 genes, respectively, in the lungs and blood of 
the exposed rats. Bioinformatics analysis of the differentially expressed genes demonstrated 
significant similarity in the biological processes, molecular networks, and canonical pathways 
enriched by silica exposure in the lungs and blood of the rats. Several genes involved in functions 
relevant to silica-induced pulmonary toxicity such as inflammation, respiratory diseases, cancer, 
cellular movement, fibrosis, etc, were found significantly differentially expressed in the lungs and 
blood of the silica-exposed rats. The results of this study suggested the potential application of 
peripheral blood gene expression profiling as a toxicologically relevant and minimally invasive 
surrogate approach to study the mechanisms underlying silica-induced pulmonary toxicity.
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Introduction
Occupational exposure to crystalline silica occurs in a variety of industries and occupations 
because of its extremely common natural occurrence and the wide range of products that 
contain it. In addition to sand blasting, silica milling, surface mining and tunneling, all 
activities that involve the movement of earth (e.g. mining, farming, construction, etc) are 
considered to be major sources of occupational exposure to crystalline silica. It has been 
estimated that approximately 2 million workers in USA and millions more worldwide are 
occupationally exposed to crystalline silica annually. In many cases, occupational exposure 
to crystalline silica takes place at levels much higher than the National Institute for 
Occupational Safety and Health (NIOSH) recommended exposure level (REL) of 0.05 
mg/m3 (Linch et al., 1998).
Occupational exposure to crystalline silica is a major concern among healthcare providers 
primarily because of the various diseases that are associated with the exposure. Lungs, in 
addition to being the major route for occupational exposure to crystalline silica, are also the 
primary targets for its health effects. Silicosis, an incurable, irreversible but preventable 
progressive lung fibrosis condition, is the most serious health effect associated with 
occupational exposure to crystalline silica (Mundt et al., 2011; Nasrullah et al., 2011). In 
addition, silica exposure is associated with lung cancer, cardiopulmonary failure, 
mycobacterial infection, kidney failure and autoimmune diseases (IARC, 1997; Cooper et 
al., 2002).
A major constraint in the prevention of diseases associated with occupational exposure to 
crystalline silica, especially silicosis, is the lack of practical techniques that are sensitive 
enough to detect the early pulmonary effects of silica exposure. Chest X-ray and pulmonary 
function tests are the two techniques most commonly employed to detect silicosis depending 
on the structural and/or functional impairment of the lungs associated with the onset of 
clinical symptoms of the disease. As silicosis is an irreversible and potentially life-
threatening disease, detection of the disease at a later stage following the onset of clinical 
symptoms is of no significant value in the prevention of silicosis. In view of this limitation, 
NIOSH has recommended developing practical (noninvasive or minimally invasive) and 
highly sensitive techniques capable of detecting silicosis preclinically (NIOSH, 2002). In 
compliance with the NIOSH recommendation, we have initiated a research project 
investigating the potential application of peripheral blood gene expression profiling as a 
minimally invasive and highly sensitive surrogate approach to detect silicosis prior to the 
onset of clinical symptoms of the disease. Recently, we have reported the potential 
application of peripheral blood gene expression profiling as a practical and highly sensitive 
approach to detect/predict the pulmonary effects of silica exposure in a rat model 
(Sellamuthu et al., 2011a). In that study, a gene expression signature, developed based on 
the differential gene expression profile in the blood of the silica-exposed rats, identified with 
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significant accuracy, the rats which were exposed to a very low concentration of silica (1 
mg/m3, 6 h/day, 5 days) that did not result in pulmonary toxicity detectable by the currently 
available biochemical and histological toxicity parameters.
In the present study, we have investigated the potential application of peripheral blood 
global gene expression profiling as a relevant surrogate approach to study the molecular 
mechanism(s) underlying the pulmonary effects of silica exposure. Data presented in this 
report demonstrated a remarkable similarity between the lungs and peripheral blood of the 
silica-exposed rats with respect to the biological functions and cellular pathways that are 
known to underlie the silica-induced pulmonary toxicity. Our results suggested the potential 
application of peripheral blood gene expression profiling as a mechanistically relevant, 
minimally invasive surrogate approach to study silica-induced pulmonary toxicity.
Materials and methods
Inhalation exposure of rats to crystalline silica
The entire animal experiment was conducted in an Association for Assessment and 
Accreditation of Laboratory Animal Care International approved animal facility (NIOSH, 
Morgantown, WV) following an animal protocol approved by the Institutional Animal Care 
and Use Committee. Male Fischer CDF (F344/DuCrl) rats from Charles River Laboratories 
Wilmington, MA) monitored free of viral pathogens, parasites, mycoplasmas, Helicobacter 
and CAR Bacillus, weighing approximately 150 g, were housed in ventilated isolator cages 
in specific pathogen-free and environmentally controlled conditions, on Alpha-Dri virgin 
cellulose chips and hardwood Beta-chips as bedding, and provided HEPA-filtered air, 
irradiated Teklad 2918 diet, and tap water ad libitum. Following an acclimatization period of 
approximately 2 weeks, the rats were exposed to crystalline silica (Min-U-Sil silica, US 
Silica, Berkley Springs, WV) by inhalation. Generation of an aerosol consisting of silica 
particles of respirable size and exposure of rats to the particles by inhalation were done 
exactly as reported previously from our laboratory (McKinney et al., 2009; Sellamuthu et 
al., 2011a). Stated briefly, eight rats were exposed to an aerosol containing silica at a final 
concentration of 15 mg/ m3, 6 h/day, for five consecutive days. Another group of eight rats 
exposed simultaneously to filtered air served as the control. Following termination of 
exposure to air or silica aerosol, the control and silica-exposed rats were maintained on a 12-
hour light – dark schedule with free access to food and tap water for 32 weeks. Throughout 
the period of the experiment, the rats were monitored for overt symptoms of toxicity and 
weekly body weight fluctuations, if any.
Pulmonary toxicity determination
Following the 32-week post-exposure time period, the control and silica-exposed rats were 
euthanized with an intraperitoneal injection of ≥100 mg sodium pentobarbital/kg body 
weight (Fort Dodge Animal Health, Fort Dodge, IA). Blood collected directly from the 
abdominal aorta was transferred to Vacutainer tubes (Becton-Dickinson, Franklin Lakes, 
NJ) containing EDTA as the anticoagulant and used to determine global gene expression 
profile and hematological parameters as described below.
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The right lungs of the rats were clamped off and bronchoalveolar lavage (BAL) was 
performed in the left lungs as described previously (Antonini & Roberts, 2007). The cellular 
fraction of BAL and a concentrated acellular fraction of BAL fluid (BALF) that was 
collected were used for further biochemical determination of pulmonary toxicity. The 
diaphragmatic lobe and cardiac lobe of the unlavaged right lung were inflated with 10% 
neutral-buffered formaldehyde and preserved in the same solution for histopathological 
analysis of damage. The apical lobe of the unlavaged right lung was stored in RNAlater 
(Invitrogen, Carlsbad, CA) and used in gene expression studies as described below.
BALF lactate dehydrogenase (LDH) assay
Activity of LDH, a general indicator of cytotoxicity, was assayed in the acellular fraction of 
BALF of the rats using a COBAS MIRA autoanalyzer (Roche Diagnostics Systems, Mount 
Clair, NJ) as previously reported (Antonini & Roberts, 2007).
Lung histopathology
The diaphragmatic lobes of the unlavaged right lung of the control and silica-exposed rats 
fixed in formaldehyde solution were embedded in paraffin, sectioned at a thickness of 5 µm 
and stained with hematoxylin and eosin (H & E) or Mason’s trichrome stain. The slides 
were assessed for histological changes (H & E stains) or for fibrosis (trichrome stain) by a 
board-certified veterinary pathologist (Experimental Pathology Laboratory, Inc., Sterling, 
VA).
Determination of silica-induced pulmonary inflammation
Protein concentration of the inflammatory cytokine, monocyte chemoattractant protein-1 
(MCP-1), was determined in the acellular fraction of the BALF using the Rat MCP-1 ELISA 
Kit (Invitrogen, Carlsbad, CA) and a Spectramax 250 plate spectrophotometer. The cellular 
fraction of BALF was resuspended in 1 mL of phosphate buffered saline (PBS), and the total 
number of alveolar macrophages (AMs) and polymorphonuclear leukocytes (PMNs) was 
determined using a Coulter Multisizer II and Accu Comp software (Coulter Electronics, 
Hialeah, FL). BALF cells (5 × 104) were spun onto microscope slides using a Cytospin 3 
centrifuge (Shandon Life Sciences International, Cheshire, UK) and stained with a Leukostat 
stain (Fisher Scientific, Pittsburgh, PA) to differentiate AM and PMN. Two-hundred cells 
were counted per rat, and percentages of each cell type were multiplied back across the total 
cell count to obtain total AM and PMN numbers.
Hematology
The total and differential white blood cell (WBC) counts of the blood samples obtained from 
the air and silica-exposed rats were determined by the previously described flow cytometer 
procedure (Erdely et al., 2011) using rat antibodies (BD Pharmingen, San Diego, CA). The 
leukocytes were separated into three gates (lymphocytes, monocytes, and neutrophils) by 
forward and side scattering. After collecting 3500 counting beads, the data were analyzed 
using FlowJo software (Treestar, Costa Mesa, CA).
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Gene expression analysis of lung and blood samples
RNA isolation from lung and blood samples—Total RNA was isolated from the 
apical lobe of the unlavaged right lung of the control and silica-exposed rats using an 
RNeasy Fibrous Tissue Mini Kit (Qiagen Inc., Valencia, CA). Approximately 30 mg of lung 
tissue were homogenized in buffer RLT containing β-mercaptoethanol and two 2.4 mm 
Zirconia beads (BioSpec Products Inc., Bartlesville, OK) using a mini beadbeater-8 
(BioSpec Products Inc.) for 20 seconds. The tissue homogenate was centrifuged at 10,000×g 
for 10 min at room temperature, and the RNA present in the supernatant was extracted and 
purified using RNeasy columns as directed in the RNeasy Fibrous Tissue Mini Kit protocol.
Total RNA present in blood samples of the rats was isolated using the Mouse Ribopure 
Blood RNA Isolation Kit (Ambion Inc., Austin, TX) following the protocol provided by the 
manufacturer. The RNA isolated was digested with RNase-free DNase and further purified 
using the RNeasy Mini Kit (Qiagen Inc.). Globin mRNA present in abundance in the blood 
is known to interfere with global gene expression profiling using microarray (Raghavachari 
et al., 2009); and, therefore, depletion of globin mRNA from the blood RNA samples was 
performed using the Globinclear-Mouse/Rat Globin mRNA Removal Kit (Ambion Inc.).
The integrity of the purified lung and blood RNA samples was determined using the Agilent 
2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA) and RNA was quantitated by UV 
spectrophotometry. Only RNA samples exhibiting an RNA Integrity Number (RIN) ≥8.0 
were used in the microarray analysis of the global gene expression profile.
Microarray analysis of global gene expression profile—The global gene 
expression profiles of the lungs and blood RNA samples were determined using RatRef-12 
V1.0 Expression BeadChip array (Illumina Inc., San Diego, CA). All microarray 
experiments were conducted following the Minimum Information About a Microarray 
Experiment (MIAME) guidelines. Biotin-labeled cRNA was synthesized from 375 ng RNA 
for each control and silica-exposed lung and blood sample using the Illumina Totalprep 
RNA Amplification Kit (Ambion Inc.). Details regarding chip hybridization and washing, 
scanning the chips, normalization of the microarray data and further analysis can be found in 
our recent publications (Sellamuthu et al., 2011a,b). With respect to the statistical analysis, 
Illumina BeadArray expression data were analyzed in Bioconductor (Gentleman et al., 2004) 
using the “lumi” and “limma” packages. The “lumi” Bioconductor package was specifically 
developed to process Illumina microarrays and covers data input, quality control, variance 
stabilization, normalization, and gene annotation. Normalized data were then analyzed using 
the “limma” package in R (Smyth, 2004). In short, limma fits a linear model for each gene, 
generates group means of expression, conducts pairwise comparisons between selected 
groups, and calculates p values using empirical Bayes methodology. The log fold changes of 
gene expression between the control and silica-exposed samples were converted to standard 
fold changes and raw p values were corrected for false discovery rate (FDR) using the 
Benjamini and Hochberg method (Benjamini & Hochberg, 1995). Only genes with FDR p 
value <0.01 and fold change in expression > 1.5 compared with the control samples were 
considered as significantly differentially expressed genes (SDEGs) and used as input for 
further bioinformatics analysis. The microarray data presented in this manuscript have been 
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deposited in the Gene Expression Omnibus (GEO) Database (http://www.ncbi.nlm.nih.gov/
geo) and are accessible through GEO accession number GSE36208.
Quantitative real-time polymerase chain reaction (QRT-PCR) analysis—Seven 
genes which exhibited a significant difference in expression (FDR p < 0.01 and fold change 
>1.5) in both the lung and blood samples of the silica-exposed rats compared with the 
control rats and belonging to the IPA biological function category inflammatory response 
(details about IPA analysis and findings are presented below) were selected for QRT-PCR 
analysis to confirm the microarray data. The nucleotide sequences of the primers used in the 
QRT-PCR analysis of the selected genes and the housekeeping gene, β-actin, are presented 
in Supplementary Table S1. The PCR amplification, detection of the PCR amplified gene 
products, and their quantitations were performed with a 7900 HT Fast Realtime PCR 
machine and SYBR Green PCR MasterMix (Applied Biosystems, Foster City, CA). The 
specificity and integrity of the PCR products were determined by analyzing the dissociation 
curves of all PCR amplified gene products. The expression levels of the genes were 
normalized to that of the housekeeping gene, and the fold changes in expression compared 
with the controls were calculated using the formula 2^(−(ΔCt_target gene − ΔCt_ 
housekeeping gene).
Bioinformatics analysis of SDEGs—Bioinformatics analysis of the SDEGs (both 
upregulated and downregulated in expression in the lungs and blood samples of silica-
exposed rats compared with the controls) was conducted using Ingenuity Pathway Analysis 
software (IPA, Ingenuity Systems, www.ingenuity.com). IPA software is designed to map 
the biological relationship of the uploaded genes and classify them into categories of 
biological functions, molecular networks, and canonical pathways according to published 
literature in the database. Fisher’s exact test was conducted to calculate a p value to 
determine the significance of a particular biological function, molecular network, or 
canonical pathway enriched by silica exposure in the rat lungs and blood. The criteria 
required for a biological function, molecular network, or canonical pathway to be considered 
significantly enriched in response to silica exposure and toxicity was that the category 
within a gene set was represented with a significance level for enrichment of p < 0.05. The 
biological functions, molecular networks, and canonical pathways significantly enriched (p 
< 0.05) but represented by fewer than 5 genes were filtered out to identify the functions, 
networks, and pathways most robustly perturbed by silica exposure in the rat lung and blood 
samples.
Statistical analysis of the data
Non-microarray data between the silica-exposed and control rats were compared using the 
one-way ANOVA test. Post hoc comparisons were made with Fisher’s least significant 
difference (LSD) test. The level of statistical significance was set at p < 0.05.
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Results
Pulmonary toxicity in the silica-exposed rats
Compared with the control rats, the BALF LDH activity in the silica-exposed rat lungs was 
approximately three-fold higher (p< 0.05) at the 32-week post silica exposure time interval 
(Figure 1). Silica-induced pulmonary toxicity in the rats was further confirmed by 
histological analysis of the lungs (Figure 2). Compared with the control rats, significant 
histological changes suggesting silica-induced pulmonary toxicity were detected in the lungs 
of the silica-exposed rats. The major histological changes noticed in the rat lungs in response 
to silica exposure were multifocal areas of inflammation and type II pneumocyte 
hyperplasia. Inflammation ranged in degree with the majority of animals exhibiting sub-
acute and the remaining animals exhibiting chronic or chronic-active inflammation. The 
affected areas of the lungs contained increased numbers of alveolar macrophages present in 
the alveolar space. These AMs were typically large and round with a foamy cytoplasm. In 
addition, accumulation of neutrophils, lymphocytes, and plasma cells was noticed in the 
lungs of the silica-exposed rats. When lungs were stained with trichrome, many of the areas 
affected by inflammation had increased fibrosis characterized by thickening of the alveolar 
septae with a blue stained cellular matrix, interpreted to be collagen (Figure 2). In general, 
the severity of silica-induced pulmonary damage in the rats was higher at the 32-week post-
exposure time interval compared with the early post-exposure time intervals of 0–16 weeks 
(Sellamuthu et al., 2011a).
Induction of inflammation in silica-exposed rats
A significant increase in the number of AMs and PMNs and in the concentration of MCP-1 
was noticed in the BALF of the silica-exposed rats compared with the control rats (Figure 
3A, 3B and 3C), suggesting silica-induced pulmonary inflammation. As described above, 
histological analysis of the lung samples further supported silica-induced pulmonary 
inflammation in the rats. A significant increase in the number of neutrophils in the blood of 
the silica-exposed rats compared with the control rats was also noticed (Figure 3D), 
providing evidence for silica-induced systemic inflammation. Overall, a further progression 
in silica-induced pulmonary inflammation was seen in the rats at the 32-week post-exposure 
time interval compared to the earlier time intervals of 0–16 weeks (Sellamuthu et al., 
2011a).
Differential gene expression profiles in the lungs and blood of silica-exposed rats
Microarray analysis of global gene expression profile identified a significant differential 
expression (> 1.5-fold change and FDR p < 0.01) of 520 and 537 genes, respectively, in the 
lungs and blood of the silica-exposed rats compared with the controls. A complete list of the 
SDEGs in the lungs and blood of the silica-exposed rats along with their fold changes in 
expression and FDR p values compared with the controls are presented in Supplementary 
Table S2 and Supplementary Table S3. Of the SDEGs, 181 genes were found to be common 
between lungs and blood. Details regarding the number of significantly differentially 
expressed genes including those which were overexpressed and underexpressed in the lungs 
and blood of the silica-exposed rats compared with the controls, are presented in Figure 4. In 
general, the number of SDEGs detected in the lungs and blood of the silica-exposed rats at 
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the 32-week postexposure time interval was more than those detected at the earlier time 
intervals of 0–16 weeks (Sellamuthu et al., 2011a; 2012).
The RT-PCR analysis results confirmed the differential expression (> 1.5-fold change) of all 
the blood genes selected based on the microarray results (Figure 5). In the case of the lung 
tissue, three genes were confirmed to be differentially expressed at a level of > 1.5-fold 
change.
The expressions of JunB and SLP1 were slightly less than but close to 1.5-fold – the criteria 
employed to select the SDEGs on the basis of the microarray data.
Bioinformatics analysis of SDEGs in the lungs and blood of silica-exposed rats
Bioinformatics analysis by IPA of the SDEGs in the lungs of the silica-exposed rats 
provided molecular insights into the mechanisms potentially underlying the pulmonary 
effects of silica. Inflammatory response and cancer were among the highly ranked IPA 
biological function categories significantly enriched in the lungs and blood of the silica-
exposed rats (Figure 6 and Supplementary Table S4–Supplementary Table S7). 
Inflammatory response ranked second among the significantly enriched IPA biological 
function categories in the lungs of the silica-exposed rats further confirming the central 
prominent role played by inflammation in silica-induced pulmonary toxicity (DiMatteo & 
Reasor, 1997; Barbarin et al., 2005). Results of the IPA bioinformatics analysis of the 
canonical pathways further suggested the prominent role played by inflammation in silica-
induced pulmonary toxicity (Figure 7). A marked similarity was noticed between the lungs 
and blood of the rats with respect to the IPA biological functions and canonical pathways 
enriched by their pulmonary exposure to crystalline silica (Figures 6 and 7). A similar 
observation was also made with respect to the IPA molecular networks which were 
significantly enriched in the lungs and blood of the silica-exposed rats (data not presented).
Discussion
A significant increase in mining, refining, and manufacturing, as well as the increased use of 
products containing potentially toxic agents over the past several decades, has resulted in a 
corresponding increase in human exposure to toxic agents capable of resulting in adverse 
health effects including potentially life-threatening diseases. It has been reported that 
millions of workers in the USA and elsewhere are occupationally exposed to crystalline 
silica (Sanderson, 1986), and in many cases the exposure takes place at levels as high as 10-
fold higher than the NIOSH recommended exposure level of 0.05 mg/m3 (Linch et al., 
1998). In addition to having an association with silicosis, a life-threatening but preventable 
pulmonary disease, occupational exposure to crystalline silica is associated with the 
development of autoimmune diseases, rheumatoid arthritis, chronic renal diseases, lupus, 
and cancer (Parks et al., 1999; Steenland et al., 2001). A better understanding of the 
molecular mechanisms underlying the pulmonary effects of silica exposure as well as 
developing the capability to detect the adverse pulmonary effects at an early stage (prior to 
the appearance of clinical symptoms of toxicity or disease) are critical in preventing diseases 
and mortality associated with occupational exposure to crystalline silica.
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Laboratory animals have been used extensively in the past to study the pulmonary effects of 
silica exposure (Carter & Driscoll, 2001; Porter et al., 2001; Castranova et al., 2002), and the 
rat model employed in the current study appears to be consistent with the progression of 
human silicosis. Based on the findings of epidemiological studies, it has been demonstrated 
that silicosis may develop and/or progress in workers even after cessation of their 
occupational exposure to crystalline silica (Kreiss & Zhen, 1996; Miller et al., 1998). 
Compared to our related study (Sellamuthu et al., 2011a), which examined rats 0–16 weeks 
after a 1 week crystalline silica exposure, inflammation progressed and was more severe at 
32-weeks. In addition, type II cell hyperplasia and fibrosis were prominent histological 
findings indicating the progression of lung disease due to silica exposure. Analogous to the 
human situation, the pulmonary toxicity induced by inhalation exposure of rats to silica for 1 
week further progressed through the 32-week postexposure time interval. The mechanisms 
potentially underlying silica-induced pulmonary toxicity include the induction of oxidative 
stress (Fubini & Hubbard, 2003), apoptosis (Porter et al., 2002), and chronic inflammation 
(Sato et al., 2008). Based on the results obtained from a large number of in vitro and in vivo 
studies, it has been fairly well established that the induction of inflammation plays a 
predominant and central role in the pulmonary effects of silica exposure (Castranova, 2004; 
Hornung et al., 2008; Thakur et al., 2009). The current study also shows significant chronic 
inflammation in the lungs as well as systemic inflammation detected in the blood.
In the current study, we employed microarray technique for detecting the differentially 
expressed genes in the lungs and blood of the rats to provide further insight into the 
mechanisms of silica-induced pulmonary toxicity. Bioinformatics analysis of the 
significantly differentially expressed genes by IPA identified the biological functions, 
molecular networks, and canonical pathways that were significantly enriched in response to 
pulmonary exposure to silica and, therefore, provided molecular insights into the 
mechanisms potentially underlying silica-induced pulmonary toxicity. It has been fairly well 
established that inhaled silica particles interact with AMs and alveolar epithelium to result in 
the generation of reactive oxygen species (ROS) (Porter et al., 2002), induction of 
inflammation (Porter et al., 2004) and fibrosis (Porter et al., 2001) culminating in silicosis. 
In agreement with our previous reports (Sellamuthu et al., 2011a,b, 2012), several genes 
involved in the generation of ROS as well as in the cellular response to oxidative stress, viz: 
superoxide dismutase 2 (SOD2), hemeoxygenase 1 (HMOX1), metallothionein 1A (MT1A), 
neutrophil cytosolic factor 1 (NCF1), and NADPH oxidase organizer 1 (NOX01), were 
found significantly overexpressed in the lungs of the silica-exposed rats suggesting the 
potential involvement of oxidative stress in the induction of pulmonary toxicity detected in 
our rat model. As presented in Figures 6 and 7 and in agreement with our previous report 
(Sellamuthu et al., 2011a) as well as those of other investigators (Porter et al., 2004; 
Castranova, 2004), induction of inflammation appeared to be the major mechanism 
underlying the silica-induced pulmonary toxicity. Many of the canonical pathways that were 
significantly enriched in the silica-exposed rat lungs were those involved in an inflammatory 
response (Figure 7). Endogenous danger signals or alarmins that are released from AMs 
following cell death (Chen & Nuñez, 2010) may interact with pattern recognition receptors 
(PRRs) to result in pulmonary inflammation. The transcript for one such alarmin, SA100A8, 
was significantly overexpressed in our rat model. Transcript for MYD88, an adaptor 
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molecule for TLR (Xiang & Fan, 2010) and CASP1, an adaptor molecule for NLRP3 
inflammasome complex (Cassel et al., 2008) were also significantly overexpressed in our rat 
model. A definite role for NLRP3 inflammasome complex in silicosis has been previously 
demonstrated (Cassel et al., 2008). Activation of the PRRs and other inflammatory response 
receptors along with their pathways results in the release of proinflammatory cytokines and 
chemokines resulting in the induction of inflammation. The transcript for IL1β, a 
proinflammatory cytokine that plays a major role in silica-induced pulmonary inflammation 
and damage (Franchi et al., 2009), was significantly overexpressed in our rat model. The 
significant overexpression of the transcripts for genes involved in tissue remodeling and 
fibrosis viz: haptoglobin (HP), arginase 1 (ARG1), members of the metalloproteinase 
(MMP) family, secreted phosphoprotein 1 (SPP1), and JUNB in the silica-exposed rat lungs 
may account for the fibrosis detected in the lungs of the silica-exposed rats in our study 
(Figure 2). It is noteworthy that many of the genes whose expressions were significantly 
different in the lungs (Supplementary Table S2) and are mechanistically relevant to silica-
induced pulmonary toxicity were also significantly differentially expressed in the blood of 
the silica-exposed rats (Supplementary Table S3 and Sellamuthu et al., 2011a), and a 
remarkable similarity was seen in the IPA biological functions and canonical pathways that 
were significantly enriched in the lungs and blood of the silica-exposed rats (Figures 6 and 
7). These results, therefore, suggested the potential application of peripheral blood gene 
expression profiling as a mechanistically relevant and practical surrogate approach to study 
the pulmonary toxicity induced by crystalline silica.
The data presented in this report have clearly demonstrated the ability of silica particles 
deposited in the rat lungs to result in global gene expression changes in peripheral blood. 
Even though the exact mechanism(s) underlying the blood gene expression changes taking 
place in the rats exposed to crystalline silica by inhalation are currently unknown, several 
possibilities are worthy of consideration. Mainly because of poor solubility and the 
relatively large size (mass median aerodynamic diameter =1.6 µm), it is unlikely that the 
silica particles employed in our study would have crossed the lung-blood barrier to reach the 
peripheral blood. This argument is supported by the results of a previous study (Absher et 
al., 1992) which reported undetectable level of silica in the blood of rats at 60-days 
following a 1-week exposure (a much shorter post-exposure time interval compared to the 
present study) to a higher concentration of cristobalite (silicon dioxide) particles of an even 
smaller size (mass median aerodynamic diameter = 0.9 µm) than that was employed in our 
study. The most logical factor potentially contributing to the changes seen in the blood gene 
expression profile of the rats in response to their pulmonary exposure to silica, therefore, 
seems to be an indirect effect. Pulmonary exposure to crystalline silica results in the 
generation of a wide array of mediators of toxicity such as reactive oxygen and nitrogen 
species (Fubini & Hubbard, 2003), inflammatory mediators (Porter et al., 2004), danger 
signals (Chen & Nuñez, 2010) and fibrogenic signals (O’Reilly et al., 2005). One such 
toxicity mediator that deserves special attention with respect to the differential gene 
expression profile seen in the blood of the silica-exposed rats is hyaluronan, a low molecular 
mass extracellular membrane fragment, released into the BALF and peripheral blood 
following silica and other particulate material-induced pulmonary toxicity (Cantin et al., 
1992; Eklund et al., 1991; Fraser et al., 1997). Hyaluronan functions as a chemoattractant 
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and its chemotactic activity is mediated through its interaction with CD44 (Tzircotis et al., 
2005). Interaction of hyaluronan with its receptors, TLR and CD44, is known to result in an 
inflammatory response (Campo et al., 2012) through activation of macrophages and 
recruitment of neutrophils into the lungs (Jiang et al., 2005). The proinflammatory cytokine, 
MCP-1, plays a prominent role in the hyaluronan-mediated inflammatory response 
(Haslinger et al., 2001). Significant overexpression of TLR2, TLR4 and CD44 detected in 
the blood (Sellamuthu et al., 2011a and Supplementary Table S3) and activation of MCP-1 
seen in the BALF of the silica-exposed rats (Figure 3C) further support the potential role of 
hyaluronan in the pulmonary and systemic inflammation as well as in the differential 
expression of blood genes noticed in the silica-exposed rats.
The superior sensitivity of gene expression changes taking place in a target organ as an 
indicator of toxicity compared to the traditional biochemical and histological toxicity 
markers has been demonstrated previously (Heinloth et al., 2004). However, as summarized 
in Table 1, the results presented in this study as well as those presented in recent 
publications (Bushel et al., 2007; Lobenhofer et al., 2008; Umbright et al., 2010; Sellamuthu 
et al., 2011a) suggest that peripheral blood gene expression profiling may be an even more 
sensitive approach to detect target organ toxicity than gene expression profiling in target 
organs. In addition to the superior sensitivity, the present study results demonstrated that the 
gene expression changes taking place in the peripheral blood of the silica-exposed rats are 
mechanistically relevant to the pulmonary toxicity induced by the silica particles deposited 
in the lungs following inhalation exposure. Therefore, peripheral blood gene expression 
profiling appears to provide an opportunity to develop markers of target organ toxicity that 
are not only superior in sensitivity compared with the existing biochemical and histological 
toxicity markers (Sellamuthu et al., 2011a) but mechanistically relevant to the target organ 
toxicity. The capability to determine the mechanisms underlying the onset and progression 
of target organ toxicity by employing peripheral blood gene expression profiling, a 
minimally invasive surrogate approach, has implications in developing as well as applying 
effective strategies potentially capable of preventing target organ toxicity. This would 
represent a significant advancement considering silicosis, the principal pulmonary effect of 
occupational exposure to silica, is an irreversible but preventable, life-threatening 
pulmonary condition. While the findings of the present study are encouraging, additional 
studies are warranted, especially, those designed to determine whether peripheral blood gene 
expression changes can detect toxicity that is specific to both the target organ and a given 
toxicant, especially under conditions of human exposure to toxic agents.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Lactate dehydrogenase activity in rat lungs. Rats were exposed to crystalline silica or 
filtered air and lactate dehydrogenase activity was determined in bronchoalveolar lavage 
fluid (BALF) as described in the text. Values represent mean ± SE of eight rats per group. 
*Statistically significant (p < 0.05) compared to the control rats.
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Figure 2. 
Photomicrographs of lungs from control and silica-exposed rats. Lung samples obtained 
from control and crystalline silica-exposed rats were sectioned and stained with H & E (top 
panel) or Masson’s trichrome stain (bottom panel) as described in the text. The arrow and 
arrowhead in the H & E stained sections show type II pneumocyte hyperplasia and alveolar 
space filled with macrophages and neutrophils, respectively, in the silica-exposed rat lungs. 
The arrow and arrowhead in the trichrome stained sections show thickened alveolar septae 
and type II pneumocyte hyperplasia lining the alveolar septae, respectively, in the silica-
exposed rat lungs Magnification: H & E = ×20; trichrome = ×40.
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Figure 3. 
Bronchoalveolar lavage fluid (BALF) and blood parameters of inflammation in the control 
and silica-exposed rats. Rats were exposed to crystalline silica or air and total number of 
alveolar macrophages (AMs) (A) and polymorphonuclear leukocytes (PMNs) (B) and 
concentration of MCP-1(C) were determined in the BALF as described in the text. Number 
of neutrophils (D) in the blood of the rats was also determined. Values represent mean ± SE 
of eight rats per group. *Statistically significant (p < 0.05) compared to the control rats.
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Figure 4. 
Number of significantly differentially expressed genes (SDEGs) in the lungs (L) and blood 
(B) of silica-exposed rats. Rats were exposed to crystalline silica or air and gene expression 
profile was determined in the lungs and blood by microarray analysis. Genes with >1.5-fold 
change and a false discovery rate (FDR) p < 0.01 in the silica-exposed rat lungs and blood 
compared with the corresponding control samples were considered as significantly 
differentially expressed. SDEGs – Significantly differentially expressed genes in the lungs 
and blood of the silica-exposed rats compared with the control samples; Upregulated – genes 
which were significantly overexpressed in the lungs and blood of the silica-exposed rats 
compared with the control samples; and Downregulated – genes whose expressions were 
significantly downregulated in the lungs and blood of the silica-exposed rats compared with 
the control samples.
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Figure 5. 
Validation of microarray results by QRT-PCR. A set of seven genes whose expressions were 
significantly different in the lungs and blood of the silica-exposed rats as indicated by the 
microarray findings were analyzed by QRT-PCR as described in the “Materials and 
methods” section. The microarray data presented is the mean fold change (n= 6) and the 
QRT-PCR data presented is mean fold change ± SE (n= 6) of silica-exposed rats compared 
with the control. A. Lung results, B. Blood results. *Statistically significant (p < 0.05) 
compared to the control rats.
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Figure 6. 
Enrichment of IPA biological functions in the lungs and blood of silica-exposed rats. 
Bioinformatics analysis of the significantly differentially expressed genes identified in the 
silica-exposed rat lungs and blood was done using IPA software. The top 10 significantly 
enriched biological functions in the lungs of the silica-exposed rat lungs compared with the 
control rat lungs and the same biological functions in the blood samples are presented to 
demonstrate the similarity in gene expression profile between lungs and blood of the silica-
exposed rats. Data represents the mean of six rats per group.
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Figure 7. 
Enrichment of IPA canonical pathways in the lungs and blood of silica-exposed rats. 
Bioinformatics analysis of the significantly differentially expressed genes in the silica-
exposed rat lungs and blood was done using IPA software. The top eight significantly 
enriched canonical pathways in the silica-exposed rat lungs compared with the control rat 
lungs and the same pathways in the blood samples of the rats are presented to demonstrate 
the similarity in the gene expression profile between lungs and blood of the silica-exposed 
rats. Data represents the mean of six rats per group.
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Table 1
Correlation co-efficients (r2 values) for the relationship between silica-induced pulmonary toxicity (BALF 
LDH, PMN and MCP-1) and the number of significantly differentially expressed genes in the lungs and blood 
of silica exposed rats. The toxicity measurements and the number of differentially expressed genes in the silica 
exposed rats at postexposure time intervals of 0, 1, 2, 4, 8, 16, and 32 weeks following a one week exposure 
were used to determine the correlation co-efficients (r2 values). The 32-week data were obtained from the 
present study while data for all other post-exposure time intervals were obtained from our previous 
publications (Sellamuthu et al., 2011a, 2012).
BALF LDH BALF PMN BALF MCP-1
Lung DEG 0.776 0.879 0.927
Blood DEG 0.831 0.923 0.958
BALF, bronchoalveolar lavage fluid; LDH, lactate dehydrogenase, PMN, polymorphonuclear leukocytes; DEG, differentially expressed gene.
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